|
West Pharmaceutical Services, Inc. (WST) DCF Valuation
US | Healthcare | Medical - Instruments & Supplies | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
West Pharmaceutical Services, Inc. (WST) Bundle
Whether you’re an investor or analyst, this (WST) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from West Pharmaceutical Services, Inc., you can adjust forecasts and instantly observe the effects.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,146.9 | 2,831.6 | 2,886.9 | 2,949.8 | 2,893.2 | 3,139.9 | 3,407.6 | 3,698.1 | 4,013.5 | 4,355.7 |
| Revenue Growth, % | 0 | 31.89 | 1.95 | 2.18 | -1.92 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| EBITDA | 531.7 | 895.2 | 887.9 | 844.1 | 743.9 | 888.4 | 964.1 | 1,046.3 | 1,135.5 | 1,232.3 |
| EBITDA, % | 24.77 | 31.61 | 30.76 | 28.62 | 25.71 | 28.29 | 28.29 | 28.29 | 28.29 | 28.29 |
| Depreciation | 109.1 | 122.3 | 120.6 | 137.3 | 155.4 | 148.2 | 160.9 | 174.6 | 189.5 | 205.6 |
| Depreciation, % | 5.08 | 4.32 | 4.18 | 4.65 | 5.37 | 4.72 | 4.72 | 4.72 | 4.72 | 4.72 |
| EBIT | 422.6 | 772.9 | 767.3 | 706.8 | 588.5 | 740.1 | 803.2 | 871.7 | 946.1 | 1,026.7 |
| EBIT, % | 19.68 | 27.3 | 26.58 | 23.96 | 20.34 | 23.57 | 23.57 | 23.57 | 23.57 | 23.57 |
| Total Cash | 615.5 | 762.6 | 894.3 | 853.9 | 484.6 | 830.7 | 901.5 | 978.4 | 1,061.8 | 1,152.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 385.3 | 489.0 | 507.4 | 512.0 | 552.5 | 560.4 | 608.2 | 660.1 | 716.4 | 777.4 |
| Account Receivables, % | 17.95 | 17.27 | 17.58 | 17.36 | 19.1 | 17.85 | 17.85 | 17.85 | 17.85 | 17.85 |
| Inventories | 321.3 | 378.4 | 414.8 | 434.7 | 377.0 | 442.5 | 480.2 | 521.2 | 565.6 | 613.8 |
| Inventories, % | 14.97 | 13.36 | 14.37 | 14.74 | 13.03 | 14.09 | 14.09 | 14.09 | 14.09 | 14.09 |
| Accounts Payable | 213.1 | 232.2 | 215.4 | 242.4 | 239.3 | 264.2 | 286.8 | 311.2 | 337.7 | 366.5 |
| Accounts Payable, % | 9.93 | 8.2 | 7.46 | 8.22 | 8.27 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
| Capital Expenditure | -174.4 | -253.4 | -284.6 | -362.0 | -377.0 | -328.0 | -356.0 | -386.3 | -419.3 | -455.0 |
| Capital Expenditure, % | -8.12 | -8.95 | -9.86 | -12.27 | -13.03 | -10.45 | -10.45 | -10.45 | -10.45 | -10.45 |
| Tax Rate, % | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 | 15.85 |
| EBITAT | 364.6 | 683.0 | 661.2 | 600.9 | 495.2 | 636.5 | 690.8 | 749.6 | 813.6 | 882.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -194.2 | 410.2 | 425.6 | 378.7 | 287.7 | 408.2 | 432.7 | 469.5 | 509.6 | 553.0 |
| WACC, % | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 | 8.67 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,838.1 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 575 | |||||||||
| Terminal Value | 12,310 | |||||||||
| Present Terminal Value | 8,122 | |||||||||
| Enterprise Value | 9,960 | |||||||||
| Net Debt | -182 | |||||||||
| Equity Value | 10,142 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | 137.62 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: West Pharmaceutical Services, Inc.'s (WST) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for West Pharmaceutical Services, Inc. (WST).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Enjoy automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: View intuitive charts and summaries that present your valuation findings clearly.
- Designed for All Skill Levels: A straightforward, accessible layout tailored for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file for West Pharmaceutical Services, Inc. (WST).
- Step 2: Review the pre-filled financial data and forecasts for West Pharmaceutical Services.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for informed investment decisions.
Why Choose This Calculator for West Pharmaceutical Services, Inc. (WST)?
- Accurate Data: Utilizes verified financials from West Pharmaceutical Services for dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Ready-made calculations remove the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the pharmaceutical sector.
- User-Friendly: Simple design and step-by-step guidance ensure accessibility for all users.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling West Pharmaceutical Services, Inc. (WST) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for West Pharmaceutical Services, Inc. (WST).
- Consultants: Deliver professional valuation insights regarding West Pharmaceutical Services, Inc. (WST) to clients quickly and accurately.
- Business Owners: Understand how companies like West Pharmaceutical Services, Inc. (WST) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to West Pharmaceutical Services, Inc. (WST).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled West Pharmaceutical Services, Inc. (WST) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for West Pharmaceutical Services, Inc. (WST).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.